The future of clinical trials and drug development: 2050

The future of clinical trials and drug development: 2050

A workshop held at the 18th Annual Conference of the Pharmaceutical Contract Management Group in Krakow on 9 September 2022 asked over 200 delegates what the clinical trial landscape would look like in 2050. Issues considered included who will be running the pharmaceutical industry in 2050; how ‘hea...

Full description

Bibliographic Details
Main Authors:	Timothy C Hardman, Rob Aitchison, Richard Scaife, Jean Edwards, Gill Slater, on behalf of the Committee of the Pharmaceutical Contract Management Group
Format:	Article
Language:	English
Published:	BioExcel Publishing Ltd 2023-01-01
Series:	Drugs in Context
Subjects:	artificial intelligence clinical trials innovation regulatory framework trial data
Online Access:	https://www.drugsincontext.com/the-future-of-clinical-trials-and-drug-development-2050/

Similar Items

Development, implementation, and dissemination of operational innovations across the trial innovation network
by: Marisha E. Palm, et al.
Published: (2023-01-01)

Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation Network
by: Karen Lane, et al.
Published: (2023-01-01)

Editorial: Big data shaping clinical trial landscape—Greater role for pharmacoeconomics in Asia
by: Mihajlo Jakovljevic, et al.
Published: (2022-10-01)

Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies
by: Ellen Cusano, et al.
Published: (2021-11-01)

CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada
by: Stephen Sundquist, et al.
Published: (2021-09-01)

Conducting clinical trials in five Eastern European countries (EU-EECs) with a focus on Bulgaria
by: Tatyana Benisheva, et al.
Published: (2023-12-01)

CLINICAL RESEARCH IN PAKISTAN: PAST, PRESENT AND FUTURE PROSPECTS
by: Akhtar Sherin
Published: (2023-03-01)

Surfactants, Nanomedicines and Nanocarriers: A Critical Evaluation on Clinical Trials
by: Diego Alejandro Dri, et al.
Published: (2021-03-01)

Pharmacokinetic data in pregnancy: A review of available literature data and important considerations in collecting clinical data
by: Paola Coppola, et al.
Published: (2022-10-01)

Unmet Needs in Complicated Urinary Tract Infections: Challenges, Recommendations, and Emerging Treatment Pathways
by: Marantidis J, et al.
Published: (2023-03-01)

A collaborative, academic approach to optimizing the national clinical research infrastructure: The first year of the Trial Innovation Network
by: Gordon R. Bernard, et al.
Published: (2018-08-01)

Using gamification to enhance clinical trial start-up activities
by: Karen Lane, et al.
Published: (2022-01-01)

Exploring the use of routine data for recruitment and follow-up in large randomised trials
by: Edwards, DK
Published: (2019)

Design and analysis of clinical trials : concepts and methodologies /
by: Chow, Shein-Chung, 1955-, et al.
Published: (c201)

Design and analysis of clinical trials : concept and methodologies /
by: Chow, Shein-Chung, 1955-, et al.
Published: (2004)

Handbook of SOPs for good clinical practice /
by: 372694 Clive, Celine M.
Published: (2004)

What is the purpose of clinical trial monitoring?
by: Sharon B. Love, et al.
Published: (2022-10-01)

A call to address structural barriers to Hispanic/Latino representation in clinical trials on Alzheimer's disease and related dementias: A micro‐meso‐macro perspective
by: María P. Aranda, et al.
Published: (2023-04-01)

Design and analysis of clinical trials with time-to-event endpoints /
by: Peace, Karl E., 1941-
Published: (c200)

The new European Medicines Agency guideline on antidepressants: a guide for researchers and drug developers
by: Florence Butlen-Ducuing, et al.
Published: (2024-01-01)

Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development
by: Daniel Y. Lee, et al.
Published: (2019-02-01)

Development of Clinical Trials in Turkey After the Adoption of Clinical Drug Research Regulation
by: Fatih Özdener, et al.
Published: (2020-06-01)

Clinical trials in Irkutsk Scientific Center of Surgery and Traumatology: results and prospects
by: K. A. Apartsin, et al.
Published: (2016-07-01)

Radiation Oncology: Future Vision for Quality Assurance and Data Management in Clinical Trials and Translational Science
by: Linda Ding, et al.
Published: (2022-08-01)

Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine
by: Qi Wang, et al.
Published: (2023-03-01)

Translational Research in Osteogenesis Imperfecta and Cell Therapy
by: Vrisha Madhuri, et al.
Published: (2021-05-01)

The COVID-19 pandemic as a catalyst for innovation: a regulatory framework to assess fit-for-purpose innovative approaches in clinical research
by: Lada Leyens, et al.
Published: (2022-09-01)

Multiple analyses in clinical trials : fundamentals for investigators /
by: 257728 Moye, Lemuel A.
Published: (2003)

Design and analysis of quality of life studies in clinical : trialsinterdisciplinary statistics /
by: 334951 Fairclough, Diane Lynn
Published: (2002)

State and problems of clinical trials in Russian Federation
by: A A Kuzmin
Published: (2016-12-01)

ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19
by: The Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group
Published: (2023-01-01)

Increasing patient participation in oncology clinical trials
by: Jie Chen, et al.
Published: (2023-02-01)

Funding characteristics of randomised clinical trials supported by the Swiss National Science Foundation: a retrospective cohort study
by: Alain Amstutz, et al.
Published: (2018-01-01)

The Trial Innovation Network Liaison Team: building a national clinical and translational community of practice
by: Marisha E. Palm, et al.
Published: (2023-01-01)

Treatment Trials in Disorders of Consciousness: Challenges and Future Directions
by: Michael H. Marino, et al.
Published: (2022-04-01)

Academic clinical trials: Publication of study results on an international registry—We can do better!
by: Jean-Marc Hoffmann, et al.
Published: (2022-11-01)

TRUST Study: Participation in Randomized Controlled Trials and Subsequent Adherence to Visiting Medical Institutions and Taking Medications in Patients with Cardiovascular Diseases. Part I. Motives for the Patients' Participation in Clinical Trials
by: S. Yu. Martsevich, et al.
Published: (2019-09-01)

Response of the trial innovation network to the COVID-19 pandemic
by: Rachel G. Greenberg, et al.
Published: (2021-01-01)

The role of progression criteria in the design, conduct, analysis and reporting of external randomised pilot trials
by: Mellor, K
Published: (2022)

Personal benefit, or benefiting others? Deciding whether to take part in clinical trials
by: Locock, L, et al.
Published: (2011)